As the Supreme Court’s decision on Roe v. Wade took all of the oxygen out of the media greenroom, another SCOTUS decision on our healthcare, in this case, over insurance costs, was pretty much overlooked. That’s too bad because, in 2019, it involved slightly more than 6% of that budget – for individuals with end-stage renal disease (ESRD).
